Status
Conditions
About
The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
All patients with SARS-CoV-2 positive Covid-19 disease
Exclusion criteria
Loading...
Central trial contact
Claudia Spies, MD, Prof.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal